Published in Gene Therapy Weekly, March 28th, 2002
A group at McMaster University in Hamilton, Ontario, Canada, has used angiostatin gene therapy in rodent models to show it not only improves ultrafiltration but also reduces excess vascularity in the peritoneum after peritoneal membrane failure. Peter J. Margetts and fellow investigators at McMaster believe that such therapy might mitigate peritoneum injury sometimes seen in patients on long-term dialysis.
In their research, the team designated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.